当前位置:首页>SCI期刊
Expert Opinion On Investigational Drugs

Expert Opinion On Investigational Drugs

发行周期:Monthly
ISSN:1354-3784
是否SCI:SCIE
SCI稿件预审 SCI精准匹配 SCI免费指导
全部SCI期刊 医学 生物 物理 化学 农林科学 数学 地学天文 地学 环境科学与生态学 综合性期刊 管理科学 社会科学

基本信息

出版地:ENGLAND

期刊简称:EXPERT OPIN INV DRUG

通讯地址:INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ

创刊年份:1994

发行周期:Monthly

涉及方向:医学 - 药学

ESSN:1744-7658

英文期刊简介

Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development.

The Editors welcome:

Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies

Drug Evaluations reviewing the clinical and pharmacological data on a particular drug

Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials

The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D.

中文期刊简介

《Expert Opinion On Investigational Drugs》是一本由TAYLOR & FRANCIS LTD出版商出版的专业医学期刊,该刊创刊于1994年,刊期Monthly,该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 2区,小类学科:药学 2区;在JCR(Journal Citation Reports)分区等级为Q1。该刊发文范围涵盖药学等领域,旨在及时、准确、全面地报道国内外药学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为6.498,平均审稿速度较慢,6-12周。

您前面已有人排队

JCR分区

JCR分区等级 JCR所属学科 分区 影响因子
Q1 PHARMACOLOGY & PHARMACY Q1 6.498

相关推荐